在克罗恩病治疗中使用乌斯提金巴相关的不良事件:基于FAERS数据库的分析
Chiwei Guo1,2, Shujuan Zhao1
1Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, China.
这项研究使用FAERS数据分析了克罗恩病患者的乌斯特基努马布不良事件. 关键发现包括感染和严重的心脏/肝胆道疾病的风险增加,需要仔细监测.
科学领域:
- 药物监督和药物安全研究.
- 胃肠道学和免疫学.
- 现实世界的证据生成.
背景情况:
- 乌斯特基努马布已被批准用于克罗恩病 (CD),但其现实世界的安全性需要进一步描述.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库为营销后安全监测提供了宝贵的资源.
- 了解Ustekinumab的安全概况对于优化CD患者的临床管理至关重要.
研究的目的:
- 在克罗恩氏病患者中识别和描述与乌斯特基努马布治疗相关的不良事件 (AE).
- 通过分析真实世界的数据来提高乌斯提金姆的临床安全性评估.
- 使用可靠的数据挖掘技术检测安全信号.
主要方法:
- 从FAERS数据库中提取了Ustekinumab AE数据用于CD.
- 应用信号检测算法,包括ROR,PRR,BCPNN和EBGM,以识别统计学上显著的AE.
- 分类识别的AEE分为系统器官类 (SOC) 和首选术语 (PT).
主要成果:
- 在24个SOC和258个PT中确定了17187个AE和44232个信号.
- 最常见的报道是"伤害,中毒和程序并发症";"感染和感染"是高度报告的SOC.
- 显著的PT包括,Clostridium difficile感染和下呼吸道感染. 观察到肝胆道疾病 (2.24%的死亡率) 和心脏疾病 (7.50%的死亡率) 的显著信号.
结论:
- 监测常见的AEs,如感染和瘤,对于CD中的Ustekinumab至关重要.
- 不太频繁但严重的副作用,包括心脏和肝胆道疾病,需要警的临床关注.
- 潜在的罕见事件,如先天性异常,需要进一步调查和验证,并提供额外的临床数据.
更多相关视频
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
